Upload
lyphuc
View
221
Download
6
Embed Size (px)
Citation preview
Hot issues in infection prevention
Philip Russo BN MClinEpid PhD
Research FellowSchool of Nursing and Midwifery, Faculty of HealthCentre for Quality and Patient Safety Research - Alfred Health PartnershipDeakin University
@PLR_aus
Declarations
• VICNISS Coordinating Centre (Vic HAI surveillance)
• Hand Hygiene Australia
• National Centre for Antimicrobial Stewardship
• Australian Commission for Safety and Quality in Health Care
• NHMRC IC Guidelines Advisory Committee
• Australasian College for Infection Prevention and Control
Outline
• Australia's response to antimicrobial resistance – Australian data
• Hand Hygiene– Where is the elephant?
• What do we know about HAIs in Australia?
The World Health Organization (WHO) has described antimicrobial resistance as a
key global health issues
“...this serious threat is no longer a prediction for the future; it is
happening right now in every region of the world and has
the potential to affect anyone, of any age, in any country.”
WHO, 2014
MROs – Why are they important?
• Significant costs to healthcare systems
– Extended LOS
– Toxic treatments
– Diagnostic testing
– Additional healthcare visits
MROs – Why are they important?
• Significant costs to healthcare systems
– Extended LOS
– Toxic treatments
– Diagnostic testing
– Additional healthcare visits
• Increased morbidity and mortality
MROs – Why are they important?
• Now– 700,000 die annually directly from MROs
Review on AMR - UK Health 2016
MROs – Why are they important?
• Now– 700,000 die annually directly from MROs
• Do nothing, by 2050– > 10,000,000 will die annually
Review on AMR - UK Health 2016
MROs – Why are they important?
• Now– 700,000 die annually directly from MROs
• Do nothing, by 2050– > 10,000,000 will die annually
– > $100,000,000,000,000 USD (i.e one hundred trillion) cost to world
economy Review on AMR - UK Health 2016
Victorian Outbreak
Victorian Outbreak
Jan 2012 – June 2015
• 57 patients with Carbapenem producing Enterobacteriaceae (CPE)
• Increase noted in 2014, triggered a look back and increased surveillance
• Epidemiology and genomic investigation
– All cases hospital acquired
• Almost all patients treated within a single health service
Victorian Outbreak
Issues
• Multiple laboratories receiving specimens
• No statewide systematic surveillance
• CPE not reportable to Dept of Health
• No established pathways for communication to
– Other Victorian facilities
– Other State and Territories
Victorian Outbreak
Response
• CPE Incident Management Team was formed to oversee investigations and
responses to cases
– Communicable Diseases Branch – Safer Care Victoria– Surveillance systems (VICNISS and the Microbiological Diagnostic Unit), – Infectious diseases physicians and – Infection control practitioners
• Developed and revised statewide guidelines
One Health
Ant
AMR - What are we doing?
1. Communication, education and training
2. Antimicrobial stewardship
3. Surveillance
4. Infection prevention and control
5. National research agenda
6. Strengthen international partnerships
7. Clear governance arrangements
What are we doing?
AMR Strategy
1. Increase awareness and understanding of antimicrobial resistance, its
implications and actions to combat it, through effective communication,
education, and training
2. Implement effective antimicrobial stewardship practices across human
health and animal care settings to ensure the appropriate and judicious
prescribing, dispensing and administering of antimicrobials
AMR Strategy
3. Develop nationally coordinated One Health surveillance of antimicrobial
resistance and antimicrobial usage
4. Improve infection prevention and control measures across human health and
animal care settings to help prevent infections and the spread of resistance
5. Agree a national research agenda and promote investment in the discovery
and development of new products and approaches to prevent, detect and
contain antimicrobial resistance
AMR Strategy
6. Strengthen international partnerships and collaboration on regional and
global efforts to respond to antimicrobial resistance
7. Establish and support clear governance arrangements at the local,
jurisdictional, national and international levels to ensure leadership,
engagement and accountability for actions to combat antimicrobial
resistance
COAGHealth Council
AHMAC
All JursidictionsVarious AMR and AU
Strategies
ACSQHCNational AMR &AU Surveillance
Standard 3 Accreditation
DoH DoA
Federal Minister for Health
Federal Minister for Agriculture
Antimicrobial Resistance Prevention and Control Steering Group
Australian Strategic and Technical Advisory Group (ASTAG AMR)
National AMR Strategy
Resistance data
Collect and analyse data,
coordinate reporting from
existing systems, and develop
reports needed to target and
inform action on AU & AMR
Resistance data
• improve data quality
• analyse relationships between AU and AMR
• centralised national reporting
• timely identification of the emergence AMRs
Australian antimicrobial usage data
National Antimicrobial Prescribing Survey
• facilitate effective audit and review of
antimicrobial use, including compliance with
prescribing guidelines and prescribing
appropriateness
• benchmarking within hospitals across units
and wards, and between hospitals and
jurisdictions
• 2014 – 151 hospitals participated
Antimicrobial prescribing – hospitals 2015
N=281
NCAS – NAPS 2016 report
Antimicrobial prescribing –2015
Key Indicator Hospitals survey n=281
Indication documented in medical notes 72.5%
Review or stop date documented 35.5%
Surgical prophylaxis given for >24 hours 27.4%
Compliant with TGA or local guidelines 55.9%
Appropriate antimicrobial given 73.2%
NCAS – NAPS 2016 report
Aged Care NAPS
Antimicrobial prescribing –2015
Key Indicator Hospitals survey n=281
Aged Care n=186
Indication documented in medical notes 72.5% 68.4%
Review or stop date documented 35.5% 35.1%
Surgical prophylaxis given for >24 hours 27.4% -
Compliant with TGA or local guidelines 55.9% -
Appropriate antimicrobial given 73.2% -
NCAS – NAPS & AC NAPs 2016 report
Antimicrobial prescribing – Aged Care 2015
Prolonged duration of prescriptions
• 31.4% of prescriptions prescribed for longer than six months; of these – 49.0% had NO indication documented
– 2.0% had a review or stop date recorded
NCAS – AC NAPs 2016 report
Antimicrobials and infection in Aged Care
NCAS – AC NAPs 2016 report
Surgical antibiotic prophylaxis
Procedure Hospitals Number of procedures
Correct timing Correct drug & dose
24hr cease
Hip prosthesis
26 2743 91.8%
Knee prosthesis
22 3377 95.1%
CABG 6 653 89.0%
LSCS 12 3806 85.9%
ACHS Clinical Indicator Report 2016
Surgical antibiotic prophylaxis
Procedure Hospitals Number of procedures
Correct timing Correct drug & dose
24hr cease
Hip prosthesis
26 2743 91.8% 81.3%
Knee prosthesis
22 3377 95.1% 87.4%
CABG 6 653 89.0% 90.6%
LSCS 12 3806 85.9% 81.9%
ACHS Clinical Indicator Report 2016
Surgical antibiotic prophylaxis
Procedure Hospitals Number of procedures
Correct timing Correct drug & dose
24hr cease
Hip prosthesis
26 2743 91.8% 81.3% 77.4%
Knee prosthesis
22 3377 95.1% 87.4% 83.1%
CABG 6 653 89.0% 90.6% 68.7%
LSCS 12 3806 85.9% 81.9% 84.9%
ACHS Clinical Indicator Report 2016
N=886
• 22% had an antimicrobial use policy
• Poor compliance with guidelines for neutering
• Recent graduates had lower compliance than older graduates
Antimicrobial use guidelines need to be expanded and promoted to improve the responsible use of antimicrobials in small animal practice in Australia
AMR
National strategyAURANAPs
Challenges• Central coordination • Response• Animal health
Hand Hygiene
Hand Hygiene
Hand Hygiene
Number of Hospitals
TotalMoments
ComplianceRate
March 2017 951 684,327 84.6%
hha.org.au
HH compliance by HCW
hha.org.au
Correlation between hand hygiene and HAIs
25 50 75
% Compliance
Infection rate
25 50 75
% Compliance
Infection rate
Correlation between hand hygiene and HAIs
Systematic review HH studies 2009-2014
Kingston JHI 2016
Systematic review HH studies 2009-2014
Kingston JHI 2016
Systematic review HH studies 2009-2014
Kingston JHI 2016
Is 100% Compliance required?
25 50 75
% Compliance
Infection rate
At what cost?
• $2.9M per year
• Most costs related to auditing
• Do we know if it is cost effective
• Are HAI rates decreasing?
Cost effectiveness
Graves N. 2016. PLOS ONE 11(2): e0148190. https://doi.org/10.1371/journal.pone.0148190
Cost effectiveness
Graves N. 2016. PLOS ONE 11(2): e0148190. https://doi.org/10.1371/journal.pone.0148190
“The pressing question for policy makers is whether cheaper
health returns could have been achieved by allocating scarce
infection prevention budgets to programs that were displaced by
the National Hand Hygiene Initiative.”Graves N et al 2016 PLoS ONE
But then there is also…
• Patient hand hygiene
• Environmental cleaning
• Management of invasive devices
• Compliance with SP, CP and PPE
• Placement of patients
• Infections in the community
• One Health…
Bare below the elbows
Bare below the elbows
“I think the chief executive has taken this ‘bare below the elbows’ a bit far ...”
“I think the chief executive has taken this ‘bare below the elbows’ a bit far ...”
Glove use
Non-alcohol hand rubs
Lose the handshake?
Hand hygiene
• Needs to become more embedded
• Important part of the infection prevention “bundle”
Surveillance is the cornerstone of infection control
If we don’t have HAI data, how do we know what to do?
Infection prevention priorities for Australia?
• How many HAIs are there?
• Where are they happening?
• Who is at greatest risk?
• What interventions will we implement?
• How will we know if they work?
Infection prevention priorities for Australia?
• How many HAIs are there? Don’t know
• Where are they happening? Don’t know
• Who is at greatest risk? Don’t know
• What interventions will we implement? Don’t know
• How will we know if they work? We don’t know!
Infection prevention priorities for Australia?
• How many HAIs are there? Don’t know
• Where are they happening? Don’t know
• Who is at greatest risk? Don’t know
• What interventions will we implement? Don’t know
• How will we know if they work? We don’t know!
Australia is one of the few OECD countries without a
national HAI surveillance system
How many HAIs occur in Australia?
“Estimated at 200,000 HAIs per annum” Graves 2009
175,000 HAIs
2004 - 2005 data from 2 hospitals in one state
HAI in AustraliaSix states: Mandatory requirements
Differences
• Definitions
• Methods of data collection
• Risk adjustment
• Reporting
• Skill
HAI NSW QLD SA TAS VIC WA
TKR/THR Y Y N N Y Y
CABGS Y Y N N Y N
C-Sect N N N N Y N
PDS N O N N O O
CLABSI ICU Y Y Y N Y Y
HW-BSI N Y Y N N N
NHSN M M Y N Y M
Staphylococcus aureus bacteraemia (SAB)
National Safety and Quality Health Service Standards “…surveillance systems…in place”
Do we need national HAI surveillance?
Public reporting of HAI data?
• Transparency instils confidence in consumers
• May inform consumer decision
• Beware of financial penalties
The English MRSA ‘miracle’
European CDC
Victorian data
DHS website?
National HAI data will improve patient safety and quality
M.Chimera endocarditis outbreak
• July 2014 Switzerland – 6 pts with M.chimera endocarditis over 4 years– Valve replacement surgery
– Same brand Heater-Cooler unit
– M.chimera cultured from HCU water and from OR air when HCU on
M.Chimera endocarditis outbreak
• July 2015
– 11 patients from 4 Euro countries
– Valve replacement
– immunocompetent
– 6 deceased
– All had HCU in the OR
• UK
• USA
• Isolates genetically related
• Point source outbreak in the factory of the manufacturer– Supported by environmental investigations at factory
• July 2017– 108 patients worldwide
– 5 Australian (3 NSW, 1 Vic, 1 QLD)
M.Chimera endocarditis outbreak
Recommended action
– Enhanced testing of HCUs
– Cleaning
– Distance between HCU and patient
– Exhaust facing away
– Documentation, machine, patients, cleaning, testing
– High suspicion for pts returning with unexplained S & S
Lancet Infect Dis 2017;17
Procedure # studies OR P value
TKA 8 1.29 0.07
THA 6 1.08 0.65
Abdo 3 0.75 0.33
Lancet Infect Dis 2017;17
Procedure # studies OR P value
TKA 8 1.29 0.07
THA 6 1.08 0.65
Abdo 3 0.75 0.33
Evidence demonstrates no benefit from laminar flow compared with conventional turbulent ventilation in reducing risk of SSI’s in these procedures.
Laminar flow is not a preventative measure for SSI
Take home
AMR• Post antibiotic era is “emerging”
• Non-antimicrobial prevention
• AURA, NAPs
Hand hygiene• is not a fad
• Contributes to the prevention “bundle”
National Surveillance• Inform national prevention strategy
The end!